Trans Genic Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities. | Foundation Medicine Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. | ![]() Prothena Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 2010 | Founding Date 2012 | Founding Date 1999 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Norwich, GB HQ | Locations Chiyoda City, JP HQ | Locations Boston, US HQ Penzberg, DE Morrisville, US San Diego, US | Locations Dublin, IE HQ South San Francisco, US | Locations New Haven, US HQ Fitzroy, AU New York, US |
Employees | Employees 215 | Employees 236 | Employees 1,8031% decrease | Employees 163 | Employees 2252% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 25.6 m | Valuation ($) N/A | Valuation ($) 983.1 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥13.2b (FY, 2026) | Revenue (est.) $152.9m (FY, 2017) | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥10.6b (FY, 2026) | Cost of goods $85.3m (FY, 2017) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥2.6b (FY, 2026) | Gross profit $67.6m (FY, 2017) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (¥97.5m) (FY, 2026) | Net income ($161.5m) (FY, 2017) | Net income ($244.1m) (FY, 2025) | Net income N/A |
Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.
View companyFoundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.
View company
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
View companyCogstate is a neuroscience technology company.
View company